title: Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines.
abstract: It has been repeatedly observed that mixing Haemophilus influenzae type b (Hib) conjugate vaccines with acellular pertussis-containing vaccines (diphtheria-tetanus-acellular pertussis [DTPa]) resulted in a reduced magnitude of the anti-polyriboseribitolphosphate antibody response compared to that obtained when Hib vaccines were administered separately and not mixed. Nevertheless, the quality and functionality of the immune responses have been shown to be the same. With the purpose of investigating the quality of the anti-Hib immune responses that are elicited under different vaccination regimens, we report here four primary and booster-based pediatric clinical trials in which Hib vaccine was either mixed with DTPa or diphtheria-tetanus-whole-cell pertussis (DTPw)-based vaccines or was coadministered. Our results show that avidity maturation of the antibodies was lower when primary vaccination involved DTPa mixed with Hib compared to when DTPa and Hib were coadministered. No such difference was observed between mixed and separately administered Hib when associated with DTPa-hepatitis B virus-inactivated poliovirus or DTPw-based vaccines. All different combinations and regimens elicited the same opsonophagocytic and bactericidal activity as well as the same ability to protect in a passive infant rat protection assay. The functional activity of mixed DTPa-based and Hib vaccines was similar to that of mixed DTPw-based/Hib combinations. In conclusion, in vitro and in vivo data as well as postmarketing vaccine effectiveness data attest to the ability of DTPa-based/Hib combination vaccines to effectively prevent Hib-induced disease in children.
authors: GlaxoSmithKline Biologicals, Rue de l'Institut 89, 1330 Rixensart, Belgium.
authors: Philippe A
authors: PA
authors: Denoël
authors: David
authors: D
authors: Goldblatt
authors: Isabel
authors: I
authors: de Vleeschauwer
authors: Jeanne-Marie
authors: JM
authors: Jacquet
authors: Michael E
authors: ME
authors: Pichichero
authors: Jan T
authors: JT
authors: Poolman
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D000907:Antibodies, Bacterial / Q000096:biosynthesis* / Q000097:blood; D000915:Antibody Affinity; D001770:Blood Bactericidal Activity / Q000276:immunology; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000276:immunology*; D018073:Haemophilus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D019741:Haemophilus influenzae type b / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D007117:Immunization, Secondary; D007223:Infant; D051381:Rats; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D018073:Haemophilus Vaccines; D017778:Vaccines, Combined
references: Vaccine. 2000 Nov 22;19(7-8):825-33
references: 11115705
references: Pediatr Infect Dis J. 2000 Jul;19(7):589-91
references: 10917213
references: Pediatr Infect Dis J. 2001 Aug;20(8):767-74
references: 11734739
references: Lancet. 2003 Feb 1;361(9355):360-1
references: 12573368
references: Lancet. 2003 May 3;361(9368):1521-3
references: 12737866
references: J Infect Dis. 2003 Aug 15;188(4):481-5
references: 12898433
references: Lancet. 2004 Jul 24-30;364(9431):365-7
references: 15276396
references: J Infect Dis. 1983 Jun;147(6):1100
references: 6602191
references: J Infect Dis. 1984 Jun;149(6):1034-5
references: 6610714
references: J Infect Dis. 1986 Dec;154(6):935-43
references: 3491165
references: J Immunol. 1987 Sep 15;139(6):1999-2004
references: 3497985
references: J Infect Dis. 1988 Jan;157(1):85-90
references: 3257245
references: N Engl J Med. 1990 Nov 15;323(20):1381-7
references: 2233904
references: JAMA. 1992 Mar 18;267(11):1489-94
references: 1538539
references: J Immunol. 1995 Apr 15;154(8):4195-202
references: 7706754
references: Biologicals. 1994 Dec;22(4):397-402
references: 7779368
references: Eur J Pediatr. 1997 Jan;156(1):18-24
references: 9007484
references: Eur J Pediatr. 1997 Apr;156(4):282-7
references: 9128812
references: J Infect Dis. 1998 Apr;177(4):1112-5
references: 9534995
references: Eur J Pediatr. 1998 Mar;157(3):208-14
references: 9537487
references: Vaccine. 1998 May-Jun;16(9-10):921-7
references: 9682338
references: J Infect Dis. 1999 Aug;180(2):538-41
references: 10395878
references: J Infect Dis. 1999 Oct;180(4):1390-3
references: 10479180
references: Pediatr Infect Dis J. 2004 Oct;23(10):944-50
references: 15602195
references: Vaccine. 2005 Jul 14;23(32):4097-100
references: 15908059
references: Lancet. 2005 Jul 9-15;366(9480):144-50
references: 16005337
references: Pediatr Infect Dis J. 2006 Apr;25(4):312-9
references: 16567982
references: Emerg Infect Dis. 2006 Jun;12(6):937-41
references: 16707049
references: Pediatr Infect Dis J. 2006 Aug;25(8):706-12
references: 16874170
references: JAMA. 2000 Nov 8;284(18):2334-40
references: 11066183
references: Lancet. 1999 Dec 11;354(9195):2063-8
references: 10636384
references: Clin Microbiol Rev. 2000 Apr;13(2):302-17
references: 10756001
references: Vaccine. 2001 Mar 21;19(17-19):2280-5
references: 11257348